← Eichor
Study identifier: NCT06108063 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan

Condition: Knee Arthroplasty, Total  ·  Sponsor: Steadman Philippon Research Institute

PhasePhase 1/Phase 2
Planned participants120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to evaluate the efficacy of Losartan use post-operatively for reducing or preventing the development of arthrofibrosis and the associated adverse impacts on clinical outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Suzanne L Page, JD  ·  970-401-8770  ·  spage@sprivail.org

Luz Thede  ·  970-409-7566  ·  lthede@sprivail.org

Always discuss trial participation with your own doctor first.

Locations (1)

The Steadman ClinicVail, Colorado, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06108063